'Structure-function relationship' in glaucoma: past thinking and current concepts

An understanding of the relationship between functional and structural measures in primary open‐angle glaucoma is necessary for both grading the severity of disease and for understanding the natural history of the condition. This article outlines the current evidence for the nature of this relations...

Full description

Saved in:
Bibliographic Details
Published inClinical & experimental ophthalmology Vol. 40; no. 4; pp. 369 - 380
Main Authors Malik, Rizwan, Swanson, William H, Garway-Heath, David F
Format Journal Article
LanguageEnglish
Published Melbourne, Australia Blackwell Publishing Asia 01.05.2012
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An understanding of the relationship between functional and structural measures in primary open‐angle glaucoma is necessary for both grading the severity of disease and for understanding the natural history of the condition. This article outlines the current evidence for the nature of this relationship and highlights the current mathematical models linking structure and function. Large clinical trials demonstrate that both structural and functional change are apparent in advanced stages of disease, and at an individual level, detectable structural abnormality may precede functional abnormality in some patients, whereas the converse is true in other patients. Although the exact nature of the ‘structure–function’ relationship in primary open‐angle glaucoma is still the topic of scientific debate and the subject of continuing research, this article aims to provide the clinician with an understanding of the past concepts and contemporary thinking in relation to the structure–function relationship in primary open‐angle glaucoma.
Bibliography:istex:D15696C8BFCD4FDF8F6B406313C652FAA502D72F
ark:/67375/WNG-66T64GLB-H
ArticleID:CEO2770
research support, speakers' fees
Carl Zeiss Meditec
Some of the authors (Dr R Malik, Professor DF Garway‐Heath) received funding from the National Institute for Health Research (UK) Biomedical Research Centre at Moorfields Eye Hospital and the UCL Institute of Ophthalmology. Professor Garway‐Heath's chair at UCL is supported by funding from the International Glaucoma Association. Professor Swanson receives funding from the USPHS National Institutes for Health (EY007716).
Funding sources
Moorfields MDT
Competing/conflicts of interest
DF Garway‐Heath
research support, consultant, speakers' fees
OptoVue
Heidelberg Engineering
(co‐inventor).
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1442-6404
1442-9071
DOI:10.1111/j.1442-9071.2012.02770.x